January 23, 2020 Contact: Sarah Seagraves, Senior VP for Marketing (405) 813-2403 sseagraves@i2E.org Genio Technologies, Inc. has acquired exclusive rights to the MasSpec Pen System, a revolutionary technology from the University of Texas at Austin that is proven to accurately identify the difference between cancerous and normal tissue during surgery. OKLAHOMA CITY — i2E ManagementRead more
News
